rts logo

Who are the Institutional Holders in Leap Therapeutics Inc (LPTX)?

Leap Therapeutics Inc (NASDAQ: LPTX) is -27.86% lower on its value in year-to-date trading and has touched a low of $1.68 and a high of $5.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LPTX stock was last observed hovering at around $3.07 in the last trading session, with the day’s loss setting it -0.08%.

Currently trading at $2.99, the stock is 3.32% and 1.84% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.27 million and changing -2.61% at the moment leaves the stock 13.29% off its SMA200. LPTX registered 9.93% gain for a year compared to 6-month gain of 32.89%. The firm has a 50-day simple moving average (SMA 50) of $2.9283 and a 200-day simple moving average (SMA200) of $2.639235.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -15.77% loss in the last 1 month and extending the period to 3 months gives it a 6.41%, and is 2.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.80% over the week and 9.98% over the month.

Leap Therapeutics Inc (LPTX) has around 54 employees, a market worth around $114.57M and $0.00M in sales. Distance from 52-week low is 77.98% and -40.20% from its 52-week high. The company has generated returns on investments over the last 12 months (-131.94%).

The EPS is expected to grow by 53.42% this year

56.0 institutions hold shares in Leap Therapeutics Inc (LPTX), with institutional investors hold 48.73% of the company’s shares. The shares outstanding are 38.26M, and float is at 28.55M with Short Float at 4.99%. Institutions hold 40.30% of the Float.

Related Posts